TCL Archive Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials March 26, 1993
TCL Archive Study Finds No Benefit for Frequent CA125 Testing in Recurrent Ovarian Cancer June 5, 2009
TCL Archive Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer July 11, 2014
TCL Archive President’s FY 1988 Budget Request For NCI: $1.87 Billion, But It Really Isn’t What It Seems To Be January 9, 1987